NAM
SRNE

Nexpoint Asset Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Nexpoint Asset Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-100,000
Closed -$763K – 255
2021
Q3 		$763K Buy
+100,000
New +$763K 0.13% 76